Introduction
============

The prognosis of the patients bearing acute myocardial infarction (AMI) with ST segment elevation is related to the cardiac mechanics, and to the geometry of the left ventricle (LV) as well^[@r01]-[@r05]^. The percentage of dilatation of the LV (ventricular remodeling) and the myocardial performance mirrored by the variation of the ventricular volumes (ejection fraction) are aspects of great prognostic importance in the clinical evolution of the patients after AMI^[@r01]-[@r05]^.

The analysis of the volumes, of the geometry, and of the left ventricular function has been carried out over the past decades with the use of the two-dimensional echocardiogram / echocardiography (2D ECHO). However, this method presents limitations related to the morphological and functional analysis of the cardiac structures by virtue of the limitation of the spatial planes of observation, of the geometric inferences for the calculation of the ventricular volumes and of the possibility of shortening - \"foreshortening\" - of the geometric forms upon the rendering of the echocardiographic images^[@r06]-[@r11]^. In that sense, the three-dimensional echocardiogram (3D ECHO) has been developed - which allows for the structural analysis of the heart from multiple spatial planes of observation. The three-dimensional echocardiographic analysis of the left ventricle, when compared to the two-dimensional analysis, presents a finer proximity with the measurements obtained with methods of a better spatial resolution, such as the 64-channel ultra-rapid computed tomography and the nuclear magnetic resonance^[@r08],[@r12]-[@r14]^.

The three-dimensional echocardiography also provides for the analysis of the geometric modification of the left ventricle through the gauging of the three-dimensional sphericity index (3D SI)^[@r02],[@r15]^. This new index relates the ventricular volume to the hypothetical left ventricular volume should the LV present a spherical shape. A number of studies in the literature have related this new index of ventricular geometric analysis to the left ventricular remodeling after myocardial infarction^[@r02],[@r15]^.

Objective
=========

The purpose of the study has been that of analyzing - with the 3D ECHO - the geometric and volumetric modifications of the LV six months after AMI in patients subjected to percutaneous primary treatment by implantation of coronary endoprosthesis (Stent).

Method
======

Population
----------

The patient was eligible for the study after evaluation by the assistant doctor of the emergency services, having presented at least two of the following criteria for the diagnosis of myocardial infarction:

1 - clinical picture that is compatible with AMI;

2 - elevation of the ST segment \> 1mm in at least two derivations upon ECG of 12 derivations;

3 - dosage of markers of myocardial necrosis compatible with AMI;

Apart from the criteria for the diagnosis of AMI, the patient should present:

1- Realization of primary percutaneous coronary treatment with a \'door-to-balloon\' time of up to 90 minutes;

2- Hemodynamic stability upon realization of the percutaneous coronary intervention;

3- Signing of the free informed consent form for the realization of the study.

As criteria of exclusion from the study, there had been observed:

Image deemed to be inadequate upon the three-dimensional echocardiographic analysis;

Presence of great irregularity of the cardiac rhythm prior to percutaneous intervention (i. e.: atrial fibrillation, as a result of the difficulty upon the three-dimensional echocardiographic analysis).

The patients have been analyzed for the evidence of systemic arterial hypertension, diabetes mellitus, dyslipidemia, smoking, family history of coronary artery disease, in accordance with previously established criteria^[@r16]-[@r20]^.

Echocardiography
----------------

The two-dimensional echocardiographic analysis - with conventional and tissue Doppler - and the real-time trans thoracic three-dimensional analysis have been performed. The two-dimensional echocardiographic exams were carried out in accordance with the recommendations of the American Society of Echocardiography^[@r21],[@r22]^, in commercially available equipment (Philips IE33, Philips Medical System, Andover, MA, USA), equipped with transducer of 2-5 MHZ, and X3 matrix transducer for the rendering of the three-dimensional images. The software used for the analysis of the three-dimensional echocardiographic imagery was Q-Lab, version 5.0, Philips Medical System, Andover, MA, USA. The following echocardiographic parameters have been studied:

I - Two-dimensional echocardiogram:

End diastolic volume of the left ventricle (LVEDV); 2- End systolic volume of the left ventricle (LVESV); 3- Ejection fraction of the left ventricle (LVEF), Simpson\'s rule method.

1 - The left ventricular diameters have been measured by using the one-dimensional mode guided by the two-dimensional echocardiography.

2 - The two-dimensional sphericity index of the left ventricle has also been calculated, taking in consideration the relation between the long and short axes of the left ventricle (apical four chamber projection, in diastole)^[@r23]^, and the segmental contractility index of the left ventricle, considering the model of 17 ventricular segments.

II- Three-dimensional echocardiography:

1 - LVEDV; 2- LVESV; 3- LVEF (Picture 1); 4- index of three-dimensional left ventricular dyssynchrony % (3D DI); 5- 3D SI (Picture 2). O three-dimensional dyssynchrony index corresponds to the standard deviation % of the average of the end systolic contraction time of the segments of the left ventricle, for a mathematical model of 17 segments of the left ventricle.

2 - The three-dimensional sphericity index of the left ventricle corresponds to the ratio between the LVEDV and the volume which the left ventricle would present had its shape been spherical, in accordance with the expression below:

Three-dimensional sphericity index of the LV: LVEDV 4/3 π (D/2)^[@r03]^ where, LVEDV: end diastolic volume of the left ventricle (measured with 3D ECHO);

D: diameter of the left ventricle measured in the apical four chamber projection.

The acquisition of the three-dimensional images has been carried out after the two-dimensional echocardiographic study. The three-dimensional images have been obtained with the use of a matrix transducer - the patient being in expiratory apnea - with the image attached to the electrocardiographic record. The three-dimensional echocardiographic images have been acquired from reference points of the left ventricle, whilst taking in consideration the mitral valve ring and the ventricular apex, in sagittal and coronal projections. The reference points of the mitral valve ring have observed specific points of the mitral valve ring, whilst considering the confluence of the ring with the septum, the lateral wall, the lower wall, and the anterior wall of the left ventricle. The greatest density possible of echocardiographic lines has been considered for the outlining of the volumetric elements (*voxels*) during the acquisition of the images. The images have been stored in the hard disc of the echocardiographic equipment and analyzed \"off-line\", in specific software of the very device. The analyses have been carried out by two independent observers (MLCV and WAO).

The left ventricular remodeling (LVR) has been considered upon the occurrence of increase ≥ 15% of the LVEDV six months after the AMI, as compared to the LVEDV up to seven days after the event^[@r24]^.

The first echocardiographic exam (two-dimensional and three-dimensional) has been carried out within up to seven days after the AMI and the second exam, six months after the AMI.

Laboratory analysis
-------------------

Serum markers of myocardial necrosis (whilst considering their highest values during the progression of the AMI) and of the atrial natriuretic peptide (BNP) have been studied. Thus, there have been analyzed:

1 - Creatine kinase (CK) MB fraction and CK-MB mass;

2 - Myoglobin;

3 - Troponin I;

4 - BNP.

Statistical analysis
--------------------

The statistical analysis of the quantitative variables has been carried out through the description of the minimum and maximum values, and of the calculation of the standard deviations and averages. In relation to the qualitative variables, the absolute and relative frequencies have been calculated. The analysis of correlation between the biochemical findings and the two-dimensional and three-dimensional echocardiographic findings has been carried out by using the Pearson\'s correlation method (r), 95% of confidence interval. The intra- and the inter-observer variations have been calculated for the three-dimensional parameters measured, p \< 0.05. The data have been processed with the MedCalc system of statistical analysis, Mariakerke, Belgium.

This study has been approved by the Research Ethics Committee of the *Hospital Israelita Albert Einstein*, São Paulo, Brazil, and registered in the *Instituto Israelita de Ensino e Pesquisa Albert Einstein* - IIEPAE \[The Albert Einstein Israeli Institute of Education and Research\], under the number 293-07.

Results
=======

Within the period between March, 2007 and December, 2008, 23 patients have been studied in a prospective fashion, with the later exclusion of 2/23 (8.7%) patients from the initial series as a result of image deemed as inadequate upon the echocardiographic analysis. Thus, out of the 21 patients considered for the study, 16 (76%) men, with a mean age range of 56 ± 12 (41-87) years, which have been affected by Acute Myocardial Infarction with elevation of the ST segment, have received treatment by primary percutaneous coronary intervention (implantation of coronary endoprosthesis - *Stent*).

The demographic and clinical characteristics, the hemodynamic findings - before and after the primary percutaneous treatment - of the population studied are demonstrated in the [Table 1](#t01){ref-type="table"}. The majority of the patients of the study presented a previous history of systemic arterial hypertension (52%), and close to 1/4 of them presented diabetes mellitus, or a history of dyslipidemia or of smoking. The occurrence of a family history of atherosclerotic disease has also been expressive (43%). The patients have presented clinical evolution in group I of Killip and Kimball: 18/21 (86%); or in group II: 3/21 (14%), during the period of hospitalization.

###### 

Demographic, clinical, and angiographic characteristics before and after percutaneous coronary procedure, and factors of risk for coronary artery disease of the total population from the study (n = 21), of the patients who have presented remodeling of the left ventricle (n = 8), and of the patients who have not presented remodeling of the left ventricle (n = 13) after myocardial infarction

  **Characteristics**                                                **Group Total**           **Patients with Remodeling (n = 8)**   **Patients with no Remodeling (n = 13)**
  ------------------------------------------------------------------ ------------------------- -------------------------------------- ------------------------------------------
  Age (years)                                                        56 ± 12                   55 ± 12                                54 ±12
  (41 - 87)                                                          (41 - 83)                 (42 - 87)                              
  Gender (M/F)                                                       16/5                      5/3                                    11/2
  Smoking                                                            6 (28.5%)                 2 (25%)                                4 (31%)
  Diabetes Mellitus                                                  5 (24%)                   2 (25%)                                3 (23%)
  SAH                                                                11 (52%)                  4 (50%)                                7 (53%)
  previous CAD                                                       4 (19%)                   2 (25%)                                2 (15%)^\*^
  Dyslipidemia                                                       6 (28.6 %)                3 (37%)                                3 (23%)^\*^
  Family history - CAD                                               9 (43%)                   3 (37%)                                6 (46%)
  Involved Coronary Artery (%)                                       DA: 11 cases (52%)        DA: 4 cases (50%)                      DA: 7 cases (53%)
  CX: 6 cases(28%)                                                   CX: 2 cases (25%)         CX: 3 cases (23%)                      
  RC: 4 cases (19%)                                                  RC: 2 cases (25%)         RC: 3 cases (23%)                      
  Secondary Coronary Lesion                                          DA: 6 cases (29%)         DA: 2 cases (25%)                      DA: 3 cases (23%)
  Diagonal: 3 cases (14 %)                                           CX: 2 cases (25%)         CX: 3 cases (23%)                      
  CX: 2 cases(9.5%)                                                  \-                        \-                                     
  AMI -                                                                                                                               
  Anterior Localization                                              11 cases (52%)            4 cases (50%)                          7 cases (53%)
  Anterolateral                                                      1 case (4.7%)             \-                                     1 case (7.7%)
  Inferior                                                           4 cases (19%)             2 cases (25%)                          2 cases (15.4%)
  Inferolateral                                                      3 cases (14%)             2 cases (25%)                          1 case (7.7%)
  Lateral                                                            2 cases (9.5%)            \-                                     2 cases (15.4 % )
  \% of Obstruction of the involved coronary artery Pre-procedure    100%: 17 cases (81%)      100%: 6 cases (75%)                    100%: 10 cases (77%)
  95%: 3 cases (14%)                                                 95%: 1 case (25%)         95%: 1 case (7.7%)                     
  99%: 1 case (4.7%)                                                 99%: 1 case (25%)         99%: 2 cases (15.4%)                   
  \% of Obstruction of the involved coronary artery Post-procedure   0% : 16 cases (76%)       0%: 6 cases (75%)                      0%: 10 cases (77%)
  10%: 4 cases (19%)                                                 10%: 2 cases (25%)        10%: 3 cases (23%)                     
  20%: 1 case (4.7%)                                                 \-                                                               
  TIMI flow of the involved coronary artery Pre-procedure            TIMI 0: 18 cases (86%)    TIMI 0: 7 cases (87.25%)               TIMI 0: 11 cases (85%)
  TIMI 2: 3 cases (14%)                                              TIMI 2: 1 case (13%)      TIMI 2: 2 cases (15.4%)                
  TIMI flow of the treated coronary artery Post-procedure            TIMI 3: 21 cases (100%)   8 cases (100%)                         13 cases (100%)

M: male; SAH: Systemic Arterial Hypertension; F: female; CAD: coronary artery disease; N: normal; DA: anterior descending artery (anterior interventricular); CX: circumflex artery; RC: right coronary artery; AMI: Acute Myocardial Infarction. ^\*^p \< 0.05 (difference between the patients who have presented remodeling and between the patients who have not presented remodeling after myocardial infarction).

The two-dimensional and three-dimensional echocardiographic measurements, and the serum dosages of enzymatic markers and of BNP from the group of patients who has presented reverse remodeling of the left ventricle (n = 8 patients) and from the group of patients who has not presented reverse remodeling (n = 13) are demonstrated in the [Table 2](#t02){ref-type="table"}. The progression of the LVEDV of the total population of the study (n = 21) six months after the AMI is demonstrated in the [Chart 1](#f03){ref-type="fig"}. In the group of patients with remodeling of the left ventricle, we have observed an increase of 15.7%, p \< 0.05, of the LVEDV (analysis with 3D ECHO), and of 9.5% of the LVEDV with a two-dimensional echocardiographic analysis, six months after the myocardial infarction. In the group of patients with no remodeling of the left ventricle, we have observed an increase of 6.1% in the LVEDV (analysis with 3D ECHO), and of 9.6% in the LVEDV with a two-dimensional echocardiographic analysis, six months after the myocardial infarction. The patients (n = 21) have presented a diastolic standard of alteration of the ventricular relaxation (n = 7) and pseudonornal flow (n = 4) up to seven days after the AMI, and diastolic standard of alteration of the ventricular relaxation (n = 8) and pseudonornal flow (n = 2) six months after the AMI. No association between the diastolic dysfunction and the LVR has been made evident. Likewise, no association has been observed between the sphericity index 2D, the segmental contractility index of the left ventricle, and the ventricular remodeling 6 months after the AMI. The average time for realization of the first echocardiographic exam (two-dimensional and three-dimensional) after the AMI has been 2 ± 0.4 days.

###### 

Echocardiographic measurements and serum dosages of enzymatic markers and of BNP of the patients who have presented remodeling of the left ventricle (n = 8), and of the patients who have not presented remodeling of the left ventricle (n = 13), 6 months after myocardial infarction

  **Parameters**               **1^st^ ECHO up to 7 days after**   **2^nd^ ECHO 6M after AMI**   **1^st^ ECHO up to 7 days after**   **2^nd^ ECHO 6M after AMI**
  ---------------------------- ----------------------------------- ----------------------------- ----------------------------------- -----------------------------
  3D ECHO LVEFM                0.49 ± 0.02                         0.57 ± 0.01                   0.52 ± 0.01                         0.60 ± 0.01
  (0.35 - 0.65)                (0.37 - 0.71)                       (0.36 - 0.69)                 (0.41 - 0.71)                       
  3D ECHO LVESV (mL)           44.5 ± 8.4                          46.4 ± 8.3                    42.5 ± 7.7                          44.7 ± 6.3
  (31.2 - 58.3)                (32.8 - 58.3)                       (29.6 - 57.3)                 (30.8 - 56.3)                       
  3D ECHO LVEDV (mL)           94.3 ± 23.6                         109.1 ± 23.2^\*^              91.3 ± 21.6                         97.4 ± 18.8
  (74.5 - 103.7)               (75.3 - 120.1)                      (72.5 - 111.1)                (75.3 - 116.3)                      
  3D ECHO 17 ID % NV (\< 5%)   6.71 ± 4.32                         4.11 ± 1.31                   3.31 ± 0.95                         3.01 ± 0.76
  (0.59 - 14.6)                (0.55 - 6.2)                        (0.51 - 6.2)                  (0.53 - 4.2)                        
  3D sphericity index          0.40 ± 0.05^\*^                     0.35 ± 0.05^\*^               0.30 ± 0.05                         0.27 ± 0.05
  (0.28 - 0.43)                (0.25 - 0.37)                       (0.26 - 0.30)                 (0.22 - 0.29)                       
  2D ECHO LVDD (cm)            5.0 ± 0.2                           5.2 ± 0.1                     4.7 ± 0.1                           5.0 ± 0.1
  (4.5 - 6)                    (4.8 - 6.2)                         (4.5 - 5.3)                   (4.7 - 6.0)                         
  2D ECHO LVEF (Simpson)       0.51 ± 0.05                         0.59 ± 0.06                   0.54 ± 0.04                         0.62 ± 0.03
  (0.40 - 0.64)                (0.41 - 0.65)                       (0.41 - 0.70)                 (0.41 - 0.72)                       
  2D ECHO LVESV (mL)           49.1 ± 16.2                         49.8 ± 18.3                   47.6 ± 18.45                        47.5 ± 17.4
  (19.6 - 42.2)                (22.6 - 44.6)                       (19.6 - 39.3)                 (21.6 - 42.9)                       
  2D ECHO LVEDV (mL)           105.7 ± 21.3                        115.8 ± 20.9                  102.4 ± 21.7                        112.3 ± 23.1
  (58.9 - 104.6 )              (58.7 - 129.1)                      (57.6 - 103.2 )               (56.4 - 123.8)                      
  Sphericity index - 2D        1.77 ± 0.13                         1.83 ± 0.11                   1.78 ± 0.12                         1.86 ± 0.10
  Contractility score - LV     1.30 ± 0.12                         1.24 ± 0.11                   1.26 ± 0.15                         1.20 ± 0.13
  (NV = 1)                                                                                                                           
  Troponin I (ng/mL)           12.3 ± 8.61                         \-                            11.7 ± 9.56                         \-
  NV (0 - 0.04)                (2.70 - 33.3)                       (2.30 - 31.8)                 \-                                  
  CKMB (ng/mL)                 92.1 ± 77.8                         \-                            90.6 ± 76.4                          
  NV (0 - 3.40)                (5.9 - 256)                         (5.5 - 256)                                                       
  Myoglobin (ng/mL)            583.5 ± 227.6                       \-                            569.8 ± 219.6                       \-
  NV (0 - 62.5)                (109 - 880)                         (104 - 880)                                                       
  BNP (pg/mL)                  269.8 ± 121                         \-                            263.9 ± 120                         \-
  NV (5 - 100)                 (29 - 1054)                         (23 - 1054)                                                       

ECHO: Echocardiogram; LVEF: ejection fraction of the left ventricle; LVESV: end systolic volume of the left ventricle; LVEDV: end diastolic volume of the left ventricle; ID: index of dyssynchrony; LVDD: diastolic diameter of the left ventricle; NV: normal value; ID: index of dyssynchrony of 17 segments of the left ventricle; 3D sphericity index: Three-dimensional sphericity index. ^\*^p \< 0.05 (difference between the patients who have presented remodeling and between the patients who have not presented remodeling after myocardial infarction).

![Histogram for the demonstration of the end diastolic volumes of the left ventricle measured with three-dimensional echocardiography (LVEDV) up to seven days and six months (6M) after the myocardial infarction of the total population of the study (n = 21); 3D LVEDV: 92.3 ± 22.3 mL; 3D LVEDV 6M: 107.3 ± 26.8 mL.](abc-101-01-0043-g03){#f03}

The variation of the three-dimensional sphericity index (3D) of the left ventricle up to seven days and six months (6M) after the myocardial infarction for the total population of the study (n = 21) is demonstrated in the [Chart 2](#f04){ref-type="fig"}. The analysis of correlation (Pearson: r) between the three-dimensional sphericity index (3D) and the end diastolic volumes of the left ventricle (LVEDV), up to seven days and six months (6M) after the myocardial infarction (AMI), in the total population of the study (n = 21), is demonstrated in the [Table 3](#t03){ref-type="table"}. Remodeling of the left ventricle has been observed in 38% of the patients affected by AMI. The correlation between the 3D sphericity index measured up to seven days after the AMI and the LVEDV within six months has been 0.69, p = 0.007. For the group of patients with reverse remodeling of the LV, the correlation between the 3D sphericity index measured up to seven days after the AMI and the LVEDV within six months has been 0.74, p = 0.001. For the group of patients with reverse remodeling of the LV, the correlation between the 3D sphericity index measured within six months after the AMI and the LVEDV within six months has been 0.85, p = 0.001. For the group of patients with no reverse remodeling of the LV, the correlation between the 3D sphericity index measured up to seven days after the AMI and the LVEDV within six months has been 0.54, p = 0.001. There has been no association between the serum markers of myocardial necrosis and the occurrence of left ventricular remodeling. No association has been observed between the index of three-dimensional ventricular dyssynchrony and the left ventricular remodeling.

![Demonstration in Box-Plot of the three-dimensional sphericity index (3D) of the left ventricle up to seven days and six months (6M) after the myocardial infarction of the total population of the study (n = 21); 3D sphericity index: 0.38 ± 0.05; 3D sphericity index: 0.31 ± 0.05.](abc-101-01-0043-g04){#f04}

###### 

Correlation (Pearson: r), Confidence interval (CI) 95%, between the three-dimensional sphericity index (3D) and the end diastolic volumes of the left ventricle (LVEDV), up to seven days and six months (6M) after the myocardial infarction (AMI) in the total population of the study (n = 21)

  **Parameter**                                    **3D ECHO LVEDV**   **3D ECHO LVEDV 6M**
  ------------------------------------------------ ------------------- ----------------------
  3D sphericity index up to 7 days after the AMI   r: 0.79             r: 0.69
  CI                                               0.5539 - 0.9134     0.3611 - 08690
  p \< 0.0001                                      p = 0.0007          
  3D sphericity index 6M                           \-                   
                                                   \-                  r: 0.83
                                                   \-                  0.6147 - 0.9312
                                                   \-                  p \< 0.0001

3D sphericity index: Three-dimensional sphericity index up to seven days after the myocardial infarction; 3D sphericity index 6M: Three-dimensional sphericity index six months after the myocardial infarction; 3D ECHO LVEDV: end diastolic volume of the left ventricle up to seven days after the myocardial infarction; 3D ECHO LVEDV 6M: end diastolic volume of the left ventricle six months after the myocardial infarction.

The coefficient of intra-observer variation for the measuring of the LVEDV with 3D ECHO has been 0.94 (CI 95%: 0.81-0.97); the coefficient of inter-observer variation for the measuring of the LVEDV with 3D ECHO has been 0.92 (CI 95%: 0.80-0.96). The coefficient of intra-observer variation for the measuring of the 3D SI has been 0.93 (CI 95%: 0.80-0.95), and the coefficient of inter-observer variation for the measuring of the 3D SI has been 0.91(CI 95%: 0.77-0.94).

Discussion
==========

The left ventricular remodeling after the occurrence of AMI reflects the mechanical modifications of adaptation of the LV in the face of the ischemic event, being a factor of important prognosis in the clinical evolution of the patients^[@r01]-[@r05]^. The left ventricular dilatation, as well as the reduction in the ejection fraction of the LV, the serum levels of BNP and the functional class represent important factors of poor prognosis related to the heart failure after AMI. In the present study, 38% of the patients have presented pieces of echocardiographic evidence of ventricular remodeling, in spite of their presenting a small reduction of the LVEF within the hospitalization period (0.49 ± 0.02 upon 3D ECHO, 0.51 ± 0.05 upon 2D ECHO), of the evidence of discrete elevation of the BNP (269 ± 121 pg / mL), and of their all being within a class I or II of Killip and Kimball. This percentage of left ventricular remodeling has been similar to the findings of a study with 33 patients in which the three-dimensional echocardiographic analysis has identified LVR in 13 (39%) of the patients studied^[@r02]^.

It has also been verified that the LVR would not have been diagnosed should the volumetric analysis had been carried out with the use of the two-dimensional echocardiography (we have observed an average increase of 9.5% in the LVEDV with the two-dimensional echocardiographic analysis). The possibility of an early detection of the left ventricular remodeling takes on importance in the sense of a more aggressive pharmacological treatment for the prevention of the progression of the ventricular dilatation. In the intra-hospital analysis of 23 patients affected by AMI (the 21 patients of the current study were a part of this series), we have also observed a greater association between the serum release of BNP and the ejection fraction of the left ventricle measured with the 3D ECHO when compared to the two-dimensional echocardiography (r: - 0.7427, p \< 0.0001; - 0.5478, p = 0.001, respectively)^[@r25]^. Then, it is observed a greater association between the three-dimensional echocardiographic analysis and the cellular events (mirrored by the serum release of BNP) and the morphological and functional effect of the infarction in the left ventricle (demonstrated by the LVEF and by the ventricular remodeling), when compared to the two-dimensional echocardiographic analysis.

In relation to the new three-dimensional echocardiographic indices meant for the study of the function and of the geometry of the left ventricle (index of three-dimensional synchrony and three-dimensional sphericity index), a diverse behavior has been observed in relation to the left ventricular remodeling within six months after the AMI. No association has been detected between the index of ventricular dyssynchrony (which could represent the left intraventricular electromechanical decoupling) and the left ventricular remodeling. However, it has been verified the association between the three-dimensional sphericity index and the LVR, in a similar fashion in two previous studies with 19 and 33 patients affected by AMI^[@r02],[@r15]^. In the study with 33 patients, it has been demonstrated that values above 0.25 for the three-dimensional sphericity index would present a sensibility of 100%, a specificity of 90%, a positive predictive value of 87%, and a negative predictive value of 100%, for the forecast of RVE^[@r02]^. In the present study, in the group of patients with remodeling of the LV, the correlation (r) between the 3D sphericity index measured up to seven days after the AMI and the LVEDV in six months has been 0.74, p = 0.001. The time difference between the two studies is related to the observation period after the AMI - in the study with 33 patients, the analysis has been carried out 12 months after the event and, in our study, the analysis has been made after six months.

Thus, with the progression of the development and of a more uneventful use of the three-dimensional echocardiographic analysis, it is believed that this technique of imagery might replace the two-dimensional echocardiographic investigation in the clinical follow-up of the patients affected by myocardial infarction.

Limitation of the study
=======================

The number of patients studied has been small, thus calling for other analyses with a larger number of patients. There is still a need for the presence of echocardiographic imagery deemed to be good in order for the three-dimensional echocardiographic analysis to be carried out (two patients, 8.7% of the initial series, have been excluded from the study). Patients affected by myocardial infarction in different ventricular segments have been studied (involvement of different vascular beds), which may have provoked the heterogeneity and non uniformity in the data obtained for the analysis. The temporal aspect is important for the morphological and functional alterations of the left ventricle. The study shall be repeated in a longer period (12 and 24 months) after the ischemic event.

Conclusion
==========

In this series of patients affected by Acute Myocardial Infarction with ST segment elevation, treated by percutaneous approach, the remodeling of the left ventricle has been observed in 38% of the patients affected by AMI. The three-dimensional sphericity index has been associated to the occurrence of remodeling of the left ventricle.
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![Measurement of the ventricular volumes and of the ejection fraction of the left ventricle measured with the use of three-dimensional trans thoracic echocardiography; EDV (end diastolic volume): 102.3 mL; ESV (end systolic volume): 32.2 mL; EF (ejection fraction): 68.5%; SV (ejected systolic volume): 70.1 mL.](abc-101-01-0043-g01){#f01}

![Demonstration of the measurement of the three-dimensional sphericity index (3D SI): 0.26, in accordance with: 3D SI: LVEDV 4/3 π (D/2)3, for LVEDV: 102.3 mL (Picture 1); (D): 9.1 cm; Arrows: demonstration of the longitudinal diameter of the ventricle in apical four chamber projection.](abc-101-01-0043-g02){#f02}
